Related Experiment Video
Updated: Feb 7, 2026
Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane
Published on: February 8, 2020
Renal cell carcinoma
W Kimryn Rathmell1, Paul A Godley, Brian I Rini
1Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina 27599-7295, USA. Rathmell@med.unc.edu
Purpose Of Review:
This review focuses on recent developments in the biology and clinical therapeutics of renal cell carcinoma. Given historically limited advances in this disease, a more thorough understanding and testing of rationally targeted agents is needed.
Recent Findings:
Von Hippel-Lindau gene inactivation is observed in most clear cell renal carcinoma, driving the malignant phenotype. The resulting vascular endothelial growth factor overexpression has been targeted though various approaches, with a clear signal of anti-tumor activity. In addition, immunotherapy remains a therapeutic standard in renal cell carcinoma and an area of ongoing investigation. Observation of small renal masses may represent a viable clinical option.
Summary:
Renal cell carcinoma has become a model disease for rationally targeted therapeutics based on significant understanding of the underlying biology. Recent advances have increased the potential for meaningful improvements in clinical outcomes for renal cell carcinoma patients.
Insights
Recent advances in renal cell carcinoma (RCC) research highlight targeted therapies and immunotherapy. Understanding RCC biology offers new hope for improved patient outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Clinical Therapeutics
Background:
- Renal cell carcinoma (RCC) has historically seen limited therapeutic advances.
- Understanding the underlying molecular biology of RCC is crucial for developing effective treatments.
Purpose of the Study:
- To review recent developments in the biology and clinical therapeutics of renal cell carcinoma (RCC).
- To emphasize the need for a deeper understanding and testing of rationally targeted agents in RCC.
Main Methods:
- Review of current literature on renal cell carcinoma (RCC) biology and therapeutics.
- Analysis of targeted agents and immunotherapies in clinical use and investigation.
Main Results:
- Von Hippel-Lindau (VHL) gene inactivation is a key driver in clear cell RCC, leading to vascular endothelial growth factor (VEGF) overexpression.
- Targeted therapies against VEGF show anti-tumor activity in RCC.
- Immunotherapy is a current standard of care and an active area of research in RCC.
- Active surveillance of small renal masses is a potential clinical strategy.
Conclusions:
- Renal cell carcinoma (RCC) serves as a model for developing targeted therapies based on biological insights.
- Recent breakthroughs offer significant potential for improving clinical outcomes in RCC patients.
More Related Videos
Related Concept Videos
01:17Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
01:20Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
01:23Renal Clearance
Renal clearance refers to the volume of plasma cleared of a specific substance, such as creatinine, per unit of time. To measure clearance, urine samples are collected over a 24-hour period during each bladder voiding, followed by a single blood sample at the...
01:08Renal Drug Clearance: Comparison Between Renal Excretion Methods
Renal clearance is often associated with the renal glomerular filtration rate (GFR), which represents the rate at which plasma is filtered through the glomeruli in the kidney. When drug reabsorption is minimal and there is no active secretion, renal clearance is closely related to the...
01:23Drug Elimination: Non-Renal Routes
01:24Renal Tubule and Collecting Duct
Proximal Convoluted Tubule (PCT):
The PCT is the initial segment of the renal tubule, extending from the Bowman's capsule that encloses the glomerulus. Its convoluted structure and microvilli-lined cells increase the surface area for reabsorption. The PCT reabsorbs glucose, amino acids, sodium, and water from the filtrate, ensuring essential...